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Abstract
Background: The False Discovery Rate (FDR) controls the expected number of false positives among the positive test
results. It is not straightforward how to conduct a FDR controlling procedure in experiments with a factorial structure,
while at the same time there are between-subjects and within-subjects factors. This is because there are P-values for
different tests in one and the same response along with P-values for the same test and different responses.
Findings: We propose a procedure resulting in a single P-value per response, calculated over the tests of all the
factorial effects. FDR control can then be based on the set of single P-values.
Conclusions: The proposed procedure is very easy to apply and is recommended for all designs with factors applied
at different levels of the randomization, such as cross-over designs with added between-subjects factors.
Trial registration: NCT00959790
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Findings
The control of false positive test results has enjoined
considerable attention in the statistical literature. For an
overview of methods in case there are many compar-
isons among treatments, we refer to [1]. More recently,
Benjamini and Hochberg [2] and Storey and Tibshirani
[3] proposed procedures that control the False discov-
ery Rate (FDR). This is the expected fraction of false
positive results among all positive results. The proce-
dures are particularly suited for the analysis of multi-
ple response variables. However, they do not address
explicitly the case that there are several tests for one
and the same response variable, let alone the presence
of several sources of random variation that are to be
used for the tests. The purpose of the present com-
munication is to develop an explicit procedure for this
case.
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Motivating example
Recently, a study involving human volunteers was con-
ducted at TNO (Zeist, the Netherlands). The study has
been carried out in compliance with the Helsinki Dec-
laration, it has been approved by METOPP, Tilburg,
the Netherlands, which is an independent central-
ized ethics committee, and it has been registered at
Clinicaltrials.gov, number NCT00959790. The subjects
were healthy, non-smoking males aged 18–45 years.
All study participants signed an informed consent
form. Subjects received financial compensation for their
participation.
In the study, subjects from two body mass index (BMI)
categories were recruited. Here, we work with the results
of 14 obese subjects and 14 lean subjects. The BMI cate-
gories define a between-subjects factor at two levels.
Each of the subjects participated in the study during
two consecutive periods. Two different diets were given
to each subject, one in each period, according to a cross-
over design. The diet defines a within-subjects factor, and
its effect is to be evaluated against a random error within
subjects.
© 2013 Schoen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
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On the last day of each period, subjects completed a
physical exercise test. At three time points, blood sam-
ples were taken. This defines a within-period factor ‘time’,
which is a repeated measurement factor.
Levels of 21 oxylipids were determined in the blood
samples; the 168 samples were processed in a completely
randomized order.
Statistical model
The data were studied using the following statistical
model.
ypqr = μpqr + e2p + e1pq + e0pqr , (1)
with
μpqr = μ0 + βBp + δDpq + γBpDpq + τrTr + ηrTrBp
+ θrTrDpq + κrTrBpDpq. (2)
In formula (1), ypqr is the level of an oxylipid from subject
p (p = 1 . . . 28), period q (q = 1, 2) and time r (r = 0, 1, 2).
The measurement is the sum of an expected value mod-
eled with μpqr and random contributions modeled with
the terms e2p, e1pq, and e0pqr .
The expected value of the measurement yijk is detailed
in formula (2). We make a distinction between parame-
ters, which are to be estimated from the data, and experi-
mental variables, which indicate the BMI group, the diet,
and the time point relevant to the observation. There are
11 parameters, given in Greek alphabet, and four experi-
mental variables, given in Latin alphabet. First, the average
difference between the lean and obese groups is modeled
with parameter β and experimental variable Bp. This vari-
able takes the value 1 if subject p is obese and 0 otherwise.
The parameter β thusmodels the increase in oxylipid level
for an obese subject relative to a lean subject.
The average difference between diet 1 and diet 2 is mod-
eled with parameter δ and experimental variableDpq. This
variable takes the value 1 if subject p is given diet 2 and
0 otherwise. The parameter δ thus models the increase in
oxylipid level for diet 2 relative to diet 1.
Next, the parameter γ models the interaction between
diet and BMI group. If γ = 0, the difference between the
diets does not depend on the BMI group. If γ = 0, the
difference between the diets depends on the BMI group.
The parameters that model the average change over
time are τ1 and τ2, respectively (τ0 is taken to be zero). The
corresponding experimental variables are T1 and T2. The
first of these takes the value of 1 at time point 1 and 0 oth-
erwise; the second experimental variable takes the value
of 1 at time point 2 and 0 otherwise. So the time changes
are modeled relative to time point 0.
Further, the parameters ηr , θr and κr model the inter-
action between BMI group and time, the interaction
between diet and time and the three-factor interaction
between BMI group, diet and time, respectively.
The three random terms in formula (1) model the ran-
dom error between subjects, the random error within sub-
jects and the random error within periods, respectively.
We assume that the three random terms are independent
of each other and normally distributed with variances σ 22 ,
σ 21 and σ 20 , respectively.
The subjects can be considered as random samples from
two specific populations. Therefore, the 28 e2p are inde-
pendent and we can validly carry out an F test to assess
the difference in BMI level between the two populations.
Further, the subjects were randomly allocated to a treat-
ment order. Therefore, the 28 differences e1p1 − e1p2 are
independent and we can validly carry out F test to assess
the effect of diet and its interaction with BMI group.
There could not be a random allocation of the time
points to the blood samples. For this reason, the cor-
relations between epq0 and epq1, between epq0 and epq2,
and between epq1 and epq2 might not be equal. This
would invalidate the analysis of variance F tests for the
main effect of time and the interactions involving time.
Fortunately, the problem posed by unequal correlations
can be solved by applying a correction factor to the
degrees of freedom for the F-tests due to Greenhouse and
Geisser [4].
Sometimes, other assumptions on the random terms are
reasonable, which may lead to other denominators of the
F tests being appropriate. We refer to [5] for an extensive
discussion of this issue.
Analysis of variance
An analysis of variance for one of the oxylipids, namely
arachidonic acid, is given in Table 1.
The first two columns of the table lists the three error
strata and the 10 sources of variation present in the data.
An error stratum collects all effects that are tested against
the same variance; see [6] for a formal definition of a
stratum.
All the effects that are measured by contrasting sub-
jects are in the between-subjects stratum. The difference
between the groups, which constitutes the BMI main
effect modeled with β in formula (2), is tested against the
random error between subjects.
Each of the two diets was given to each of the subjects.
For this reason, the main effect of diet (modeled with δ in
formula (2)) and the interaction between BMI group and
diet (modeled with γ ) are tested against the random error
within subjects.
Finally, the three time points at which blood sam-
ples were taken define a third factor, time, whose
main effect (modeled with τ1 and τ2) is to be tested
against a random error within periods. The inter-
actions between BMI category and time (modeled
with η1 and η2), and between diet and time (modeled
with θ1 and θ2) are also tested against this random error.
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Table 1 Analysis of variance for arachidonic acid
Error stratum Source of variation df MS Fij Pij
Between subjects BMI 1 5.4860 9.98 0.004
error 26 0.5501
Wi thin subjects diet 1 0.0091 0.05 0.8277
BMI × diet 1 0.6465 3.43 0.0756
error 26 0.1887
Within periods time 2 4.7359 80.77 < 0.001
BMI × time 2 0.0508 0.88 0.3999
diet × time 2 0.0448 0.76 0.4453
BMI × diet × time 2 0.1538 2.62 0.08963
error 104 0.0586
NOTE: Greenhouse-Geisser  = 0.8103.
The same is the case for the three-factor interaction
(κ1 and κ2). All these effects are in the within-periods
stratum.
Further columns in the table give the degrees of freedom
(df) for each source of variation, the corresponding mean
square (MS), the value of the individual F-ratio (Fij), and
the P-value (Pij). The index i points to the error stratum,
while the index j points to the F-test within a stratum.
The four F-tests in the within periods stratum were
carried out using the Greenhouse-Geisser 
 as a correc-
tion factor to the degrees of freedom. The calculation
of this factor is implemented in most major statistical
packages. Here, 
 = 0.8103. Accordingly, the degrees
of freedom needed for the calculation of the P-values
for time and its interactions with the other two fac-
tors were 0.8103 × 2 = 1.6206 for the numerator and
0.8103 × 104 = 84.2712 for the denominator.
Under an individual false positive error rate of 0.05, the
outcome for the main effects of BMI and time are highly
significant. There is no evidence that the main effect of
diet or any interaction effect is statistically significant.
FDR in factorial experiments with a single stratum
A factorial structure of the study design permits the evalu-
ation of main effects and interactions. For two factors and
m response variables there are thus 3m tests to carry out.
The tests for main effects might not be needed once the
interaction is declared statistically significant. This is an
important notion, because the total number of the tests is
a parameter for the FDR procedure. One could start with
a procedure for them tests on active interactions only. In a
second step, the variables with significant interactions, s1,
say, are removed from further consideration, and we are
left with m − s1 variables not having a proven interaction
among the factors. We could then consider applying the
FDR procedure on 2(m− s1)main effect tests. However, it
is unclear what the performance criteria of the joint first
and second step are.
To circumvent the above problem, we propose to
replace the three tests with one omnibus F-test to see
whether the treatments differ. So we initially forget about
the factorial structure of the treatments and just check
whether there are differences between the treatment
groups. For the responses where this is indeed the case,
we suggest a follow up that does use the factorial struc-
ture, and assess themain effects and interactions using the
corresponding P-values.
The proposed replacement of individual statistical tests
can be carried out easily if all the comparisons between
the experimental groups are tested against one and the
same error. This is the case if there is just one error stra-
tum, but also if there are several strata while the effect
tests involve only one stratum. However, the proposed
replacement is not straightforward to apply when effects
are tested in several strata. For example, in the motivating
study, the error used to test the contrast between lean and
obese is different from the error used to test the contrast
between the diets. This issue is discussed next.
FDR in factorial experiments with several strata
We propose calculating a combined P-value over all the F
tests of a response variable as follows:
1. Denote the number of error strata with E, and let
i = 1, . . . ,E index the error strata.
2. Let ti be the number of F-tests carried out in stratum
i. Let Fij denote the F-value of F-test j in stratum i, let
di denote the degrees of freedom of the denominator,
and let nij denote the degrees of freedom of the
numerator. Calculate Fi = (∑ti1 nijFij)/
∑ti
1 nij.
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Under the null hypothesis, this is an F statistic with
ni =∑ nij degrees of freedom for the numerator and
di degrees of freedom for the denominator.
3. Suppose that the combined F-test in stratum i has an
associated P-value of Pi. So P(F [ni,di] > Fi|H0) = Pi.
Under the null hypothesis, Pi ∼ U(0, 1), where
U(a, b) denotes a uniform distribution with
minimum a and maximum b.
4. Combine the P-values by calculating
TE = −2 ln(∏Ei=1 Pi).
5. The overall P-value is P(X2[2E] > TE), where X2[2E] is a
random variable following a χ2[2E] distribution.
6. Apply an FDR control method to the list of overall
P-values.
7. For variables selected in step (6), study all Pij to see
which factors or interactions contributed to the
significance of TE .
The procedure to combine P-values is due to Fisher [7].
See [8] for other options to combine P-values. The crucial
condition for a correct application of Fisher’s procedure
is the independence of the P-values. This condition is
satisfied if the tests involve different error strata.
Step 6 in our procedure results in a set of variables
with an expected fraction of at most α of false positive
results among all positive results, where α is the desired
level of protection. So the FDR procedure selects variables
that show factorial effects. However, the FDR procedure
does not operate on the overall list of decisions based
on the individual Pij studied in Step 7. In this aspect,
our procedure is analogous to Fisher’s protected least
significance difference procedure [1] in one-way analysis
of variance, because, in the latter procedure, differences
between treatment groups are tested only if the overall
F-test is statistically significant.
Application
We apply the proposed procedure to the arachidonic
acid response of the motivating example. In the between-
subjects stratum, there is nothing to combine, because
there is just a single test carried out in this stratum. Recall
that the P-value for the main effect of BMI is 0.004.
The two F-tests in the within-subjects stratum are com-
bined by adding the mean squares of 0.0091 and 0.6465,
dividing by 2, and dividing the result by the error mean
square of 0.1887. The F-value for this stratum is 1.74, with
two degrees of freedom for the numerator and 26 degrees
of freedom for the denominator. The P-value is 0.20. This
P-value suggests an absence of treatment effects.
For the within-periods stratum, we multiply the mean
squares for time, BMI × time, diet × time, and the three-
factor interaction BMI × diets × time with 2, add up and
divide by 8. This results in a combined mean square of
1.2463. This mean square is tested against the error mean
Figure 1 P-values for 21 oxylipids. Each circle represents an overal
P-value for a particular oxylipid, summarizing the results of 7 statistical
tests.
square, giving an F-value of 21.26, based on 8 and 104
degrees of freedom. The degrees of freedom were cor-
rected with the Greenhouse-Geisser 
 statistic to 6.4824
and 84.2712, respectively. The associated P-value is nearly
zero. For further processing we replaced this with a value
of 10−16.
Finally, the three P-values are to be combined to one
overall value. We take –2 times the natural logarithm, and
add up. This gives X2 = 87.945. The reference distribu-
tion for this statistic is the χ2[6] distribution. The statistic
has a P-value of 8.09 × 10−17.
All the overall P-values according to the proposed pro-
cedure are shown in Figure 1. For 12 of the oxylipids,
including arachidonic acid, P < 0.05. The application of
the FDR-controlling procedures of [2] and [3], is visual-
ized in Figure 2. The P-values are ordered and plotted
against their order number. We restrict attention to the
values below 0.2, and we use a boundary value of 0.05 for
both procedures. The lower line gives the boundary values
for the Benjamini-Hochberg procedure [2]. The largest
Figure 2 Rejections for two FDR procedures. P-values below lower
line: rejected by the Benjamini-Hochberg procedure [2]; P-values
below upper line: rejected by the Storey-Tibshirani procedure [3].
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P-value below the line has order number 10. So the pro-
cedure reveals that 10 out of 21 oxylipids are affected by
the experimental factors. The upper line in Figure 2 bears
on the procedure of Storey and Tibshirani [3]. When com-
pared with the Benjamini-Hochberg procedure, two more
P-values are included in the set with q < 0.05. Note that
the set now includes all oxylipids for which P < 0.05. This
is not generally the case, however.
Some authors would favor error-control methods that
are more conservative than FDR. For example, the well-
known Bonferroni correction would compare all 21 com-
bined P-values with an error rate of 0.05/21. Clearly, the
proposed FDRmethods are more lenient than the Bonfer-
roni correction in declaring that a variable is significantly
affected by the study factors.
We like to point out that both FDR controlling proce-
dures are sensitive to strong negative correlations between
the P-values; see [9]. For the oxylipids, this is not really an
issue because the average pairwise correlation among the
oxylipids was +0.1. With three exceptions, all correlations
were above –0.3; the smallest exceptional value was –0.5.
We therefore think that our application of the FDR control
is justified.
As a final issue, we had an equal interest in all the
oxylipids and all themodel parameters. In case of variables
or parameters of primary interest, one option is to include
only these variables or parameters. This will make the pro-
cedure more powerful, because non-significant values of
the F statistic that are not of interest will tend to reduce
the overall test statistic. Alternatively, there are options
to introduce weights to the variables or parameters other
than 1 for those of primary interest and 0 for those of sec-
ondary interest. However, a discussion of these options is
beyond the scope of the present paper.
Availability of supporting data
The data set supporting the results of this article is
included within the article and its additional file called
FDR_overall_Pvalue_calculation.xlsx. The addi-
tional file shows for each of the 21 oxylipids, first the
Fij values arranged in seven rows and 21 columns. The
columns correspond to the oxylipids and the rows cor-
respond to the seven statistical tests for each individual
oxylipid. Next, the 21 values for the Greenhouse-Geisser
epsilon statistic are given. Then we give the P-values for
each of the three error strata arranged in three rows and
21 columns. The columns correspond to the oxylipids
and the rows correspond to the between-subjects, within-
subjects and within-period strata, respectively. Finally,
we give the value of the statistic TE , as calculated
in step 4 of the proposed procedure, and the corre-
sponding overall P-value for the factorial effects of the
21 oxylipids.
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